CELZ
Price
$3.31
Change
+$0.02 (+0.61%)
Updated
Sep 5, 04:47 PM (EDT)
Capitalization
8.54M
LABFF
Price
$90.61
Change
+$4.56 (+5.30%)
Updated
Jul 1 closing price
Capitalization
3.56B
Interact to see
Advertisement

CELZ vs LABFF

Header iconCELZ vs LABFF Comparison
Open Charts CELZ vs LABFFBanner chart's image
Creative Medical Technology Holdings
Price$3.31
Change+$0.02 (+0.61%)
Volume$100
Capitalization8.54M
LABORATORIOS FARMACEUTICOS ROVI SA
Price$90.61
Change+$4.56 (+5.30%)
Volume$100
Capitalization3.56B
CELZ vs LABFF Comparison Chart in %
Loading...
CELZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CELZ vs. LABFF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELZ is a Hold and LABFF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CELZ: $3.29 vs. LABFF: $90.61)
Brand notoriety: CELZ and LABFF are both not notable
CELZ represents the Biotechnology, while LABFF is part of the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CELZ: 27% vs. LABFF: 100%
Market capitalization -- CELZ: $8.54M vs. LABFF: $3.56B
CELZ [@Biotechnology] is valued at $8.54M. LABFF’s [@Pharmaceuticals: Generic] market capitalization is $3.56B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELZ’s FA Score shows that 0 FA rating(s) are green whileLABFF’s FA Score has 2 green FA rating(s).

  • CELZ’s FA Score: 0 green, 5 red.
  • LABFF’s FA Score: 2 green, 3 red.
According to our system of comparison, LABFF is a better buy in the long-term than CELZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELZ’s TA Score shows that 4 TA indicator(s) are bullish.

  • CELZ’s TA Score: 4 bullish, 5 bearish.

Price Growth

CELZ (@Biotechnology) experienced а +4.11% price change this week, while LABFF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.90%, and the average quarterly price growth was +31.78%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.80%. For the same industry, the average monthly price growth was +10.24%, and the average quarterly price growth was +86.08%.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Generic (-0.80% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LABFF($3.56B) has a higher market cap than CELZ($8.54M). CELZ YTD gains are higher at: 42.424 vs. LABFF (0.000). LABFF has higher annual earnings (EBITDA): 203M vs. CELZ (-5.81M). LABFF has more cash in the bank: 47.6M vs. CELZ (6.54M). CELZ has less debt than LABFF: CELZ (2.74M) vs LABFF (129M). LABFF has higher revenues than CELZ: LABFF (749M) vs CELZ (6K).
CELZLABFFCELZ / LABFF
Capitalization8.54M3.56B0%
EBITDA-5.81M203M-3%
Gain YTD42.4240.000-
P/E RatioN/A28.85-
Revenue6K749M0%
Total Cash6.54M47.6M14%
Total Debt2.74M129M2%
FUNDAMENTALS RATINGS
CELZ: Fundamental Ratings
CELZ
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
60
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CELZLABFF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
14%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
14%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 17 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CELZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MTOIX22.330.12
+0.54%
NYLI Income Builder Class I
VWILX117.66N/A
N/A
Vanguard International Growth Adm
SBHAX20.44N/A
N/A
Segall Bryant & Hamill All Cap Instl
DAACX10.52N/A
N/A
SEI Diversified Equity
TEMEX18.29N/A
N/A
Franklin Mutual Beacon C

CELZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELZ has been loosely correlated with LABFF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CELZ jumps, then LABFF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELZ
1D Price
Change %
CELZ100%
-1.35%
LABFF - CELZ
35%
Loosely correlated
N/A
RARE - CELZ
33%
Poorly correlated
-0.86%
MREO - CELZ
32%
Poorly correlated
N/A
WVE - CELZ
30%
Poorly correlated
+2.25%
CRSP - CELZ
29%
Poorly correlated
-0.45%
More

LABFF and

Correlation & Price change

A.I.dvisor indicates that over the last year, LABFF has been closely correlated with IMRN. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if LABFF jumps, then IMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LABFF
1D Price
Change %
LABFF100%
N/A
IMRN - LABFF
81%
Closely correlated
+1.61%
MNMD - LABFF
47%
Loosely correlated
+1.88%
CELZ - LABFF
35%
Loosely correlated
-1.35%
NVO - LABFF
29%
Poorly correlated
-1.06%
QSI - LABFF
26%
Poorly correlated
N/A
More